These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Activation of the Mu-Delta Opioid Receptor Heteromers Blocks Morphine Rewarding Effects. Requana Aradas A; Djaboub Y; McCort-Tranchepain I; Hajasova Z; Clémenceau L; Canestrelli C; Mann A; Schulz S; Delaval A; Acher F; Massotte D; Noble F; Marie N Int J Neuropsychopharmacol; 2023 Jul; 26(7):513-521. PubMed ID: 37343217 [TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens. Kabli N; Nguyen T; Balboni G; O'Dowd BF; George SR Mol Psychiatry; 2014 Sep; 19(9):986-94. PubMed ID: 24061495 [TBL] [Abstract][Full Text] [Related]
11. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities. Fujita W; Gomes I; Devi LA Br J Pharmacol; 2015 Jan; 172(2):375-87. PubMed ID: 24571499 [TBL] [Abstract][Full Text] [Related]
12. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. Cahill CM; Morinville A; Lee MC; Vincent JP; Collier B; Beaudet A J Neurosci; 2001 Oct; 21(19):7598-607. PubMed ID: 11567050 [TBL] [Abstract][Full Text] [Related]
13. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors. Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171 [TBL] [Abstract][Full Text] [Related]
14. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809 [TBL] [Abstract][Full Text] [Related]
15. Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer. Kabli N; Martin N; Fan T; Nguyen T; Hasbi A; Balboni G; O'Dowd BF; George SR Br J Pharmacol; 2010 Nov; 161(5):1122-36. PubMed ID: 20977461 [TBL] [Abstract][Full Text] [Related]
16. Clinical opioids differentially induce co-internalization of μ- and δ-opioid receptors. Bao F; Li CL; Chen XQ; Lu YJ; Bao L; Zhang X Mol Pain; 2018; 14():1744806918769492. PubMed ID: 29587571 [TBL] [Abstract][Full Text] [Related]
17. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors. Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375 [TBL] [Abstract][Full Text] [Related]
18. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain. Baker AK; Hoffmann VL; Meert TF Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154 [TBL] [Abstract][Full Text] [Related]
19. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice. Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654 [TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence. Wells JL; Bartlett JL; Ananthan S; Bilsky EJ J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]